Acknowledgments
The authors would like to thank Dr. Char Witmer (The Children’s Hospital
of Philadelphia) for providing guidance and feedback on designing the
survey and reviewing manuscript, Dr. Robert Klaassen (Children’s
Hospital of Eastern Ontario) for his guidance as a research lead in the
primary author’s institution, Dr. Donna Johnston (Children’s Hospital of
Eastern Ontario) and Dr. Yaser Mohammad (Children’s Hospital of Eastern
Ontario) for their valuable feedback.
The authors would also like to thank members of the Saudi Arabia
Pediatric Hematology Oncology Society (SAPHOS) for their support and
consideration in taking part in the survey.
References :
1. Raffini L, Huang YS, Witmer C, Feudtner C. Dramatic increase in
venous thromboembolism in children’s hospitals in the United States from
2001 to 2007. Pediatrics . 2009. doi:10.1542/peds.2009-0768
2. Witmer C, Raffini L. Treatment of venous thromboembolism in pediatric
patients. Blood . 2020;135(5):335-343.
doi:10.1182/blood.2019001847
3. Jones S, Butt W, Monagle P, Cain T, Newall F. The natural history of
asymptomatic central venous catheter–related thrombosis in critically
ill children. Blood . 2019. doi:10.1182/blood-2018-05-849737
4. Talbott GA, Winters WD, Bratton SL, O’rourke PP. A Prospective Study
of Femoral Catheter-Related Thrombosis in Children. Arch Pediatr
Adolesc Med . 1995. doi:10.1001/archpedi.1995.02170150068012
5. Mitchell LG, Andrew M, Abshire T, et al. A prospective cohort study
determining the prevalence of thrombotic events in children with acute
lymphoblastic leukemia and a central venous line who are treated with
L-asparaginase: Results of the Prophylactic Antithrombin Replacement in
Kids with Acute. Cancer . 2003. doi:10.1002/cncr.11042
6. Monagle P. Slow progress. How do we shift the paradigm of thinking in
pediatric thrombosis and anticoagulation? Thromb Res . 2019.
doi:10.1016/j.thromres.2018.07.016
7. Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing
for heritable thrombophilia. Br J Haematol . 2010.
doi:10.1111/j.1365-2141.2009.08022.x
8. Chalmers E, Ganesen V, Liesner R, et al. Guideline on the
investigation, management and prevention of venous thrombosis in
children. Br J Haematol . 2011.
doi:10.1111/j.1365-2141.2010.08543.x
9. National Institute for Health and Care Excellence. Venous
thromboembolic diseases : diagnosis , management and thrombophilia
testing. NICE Guidel . 2015.
10. Choosing Wisely. American Society of Hematology-American Society of
Pediatric Hematology/Oncology. Don’t order thrombophilia testing on
children with venous access (i.e., peripheral or central) associated
thrombosis in the absence of a positive family history. Released
December 9, 2019.
https://www.choosingwisely.org/clinician-lists/ash-aspho-avoid-thrombophilia-testing-in-children-without-positive-family-history/.
Accessed July 8, 2020
11. Monagle P, Chan AKC, Goldenberg NA, et al. Antithrombotic therapy in
neonates and children: Antithrombotic therapy and prevention of
thrombosis, 9th ed: American college of chest physicians evidence-based
clinical practice guidelines. Chest . 2012.
doi:10.1378/chest.11-2308
12. Brandão LR, Shah N, Shah PS. Low molecular weight heparin for
prevention of central venous catheterization-related thrombosis in
children. Cochrane Database Syst Rev . 2014.
doi:10.1002/14651858.CD005982.pub2
13. Avila ML, Amiri N, Stanojevic S, et al. Can thrombophilia predict
recurrent catheter-related deep vein thrombosis in children?Blood . 2018. doi:10.1182/blood-2017-10-811216
14. Monagle P, Cuello CA, Augustine C, et al. American Society of
Hematology 2018 Guidelines for management of venous thromboembolism:
Treatment of pediatric venous thromboembolism. Blood Adv . 2018.
doi:10.1182/bloodadvances.2018024786
15. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. A
metadata-driven methodology and workflow process for providing
translational research informatics support, J Biomed Inform. J
Biomed Inf . 2009. doi:10.1016/j.jbi.2008.08.010.Research
16. Harris PA, Taylor R, Minor BL, et al. The REDCap consortium:
Building an international community of software platform partners.J Biomed Inform . 2019. doi:10.1016/j.jbi.2019.103208
17. Echigoya R, Okamoto H, Uchino H, et al. Incidence and outcome of
asymptomatic deep vein thrombosis in critically ill patients: a
prospective cohort study. Crit Care . 2015. doi:10.1186/cc14406
18. Andrew M, Paes B, Milner R, et al. Development of the human
coagulation system in the full-term infant. Blood . 1987.
doi:10.1182/blood.v70.1.165.bloodjournal701165
19. Andrew M, Paes B, Johnston M. Development of the hemostatic system
in the neonate and young infant. J Pediatr Hematol Oncol . 1990.
doi:10.1097/00043426-199021000-00019
20. Andrew M, Paes B, Milner R, et al. Development of the human
coagulation system in the healthy premature infant. Blood . 1988.
doi:10.1182/blood.v72.5.1651.bloodjournal7251651
21. Goldenberg NA, Abshire T, Blatchford PJ, et al. Multicenter
randomized controlled trial on Duration of Therapy for Thrombosis in
Children and Young Adults (the Kids-DOTT trial): Pilot/feasibility phase
findings. J Thromb Haemost . 2015. doi:10.1111/jth.13038
22. Witmer CM, Sauck E, Raffini LJ. A survey of pediatric
hematology/oncology specialists regarding management of central line
associated venous thrombosis. Pediatr Blood Cancer .
2017;64(7):7-10. doi:10.1002/pbc.26383
23. Massicotte P, Julian JA, Gent M, et al. An open-label randomized
controlled trial of low molecular weight heparin for the prevention of
central venous line-related thrombotic complications in children: The
PROTEKT trial. Thromb Res . 2003.
doi:10.1016/S0049-3848(03)00099-9
24. Ruud E, Holmstrøm H, De Lange C, Hogstad EM, Wesenberg F. Low-dose
warfarin for the prevention of central line-associated thromboses in
children with malignancies - A randomized, controlled study. Acta
Paediatr Int J Paediatr . 2006. doi:10.1080/08035250600729092
25. Schroeder AR, Axelrod DM, Silverman NH, Rubesova E, Merkel E, Roth
SJ. A continuous heparin infusion does not prevent catheter-related
thrombosis in infants after cardiac surgery*. 2010;11(4):489-495.
doi:10.1097/PCC.0b013e3181ce6e29
26. Vidal E, Sharathkumar A, Glover J, Faustino EVS. Central venous
catheter-related thrombosis and thromboprophylaxis in children: A
systematic review and meta-analysis. J Thromb Haemost . 2014.
doi:10.1111/jth.12598
27. Pelland-Marcotte MC, Amiri N, Avila ML, Brandão LR. Low molecular
weight heparin for prevention of central venous catheter-related
thrombosis in children. Cochrane Database Syst Rev . 2020.
doi:10.1002/14651858.CD005982.pub3